Aspen Aerogels, Inc. (NYSE:ASPN) Receives $28.70 Consensus PT from Analysts

Aspen Aerogels, Inc. (NYSE:ASPNGet Free Report) has been given an average rating of “Buy” by the nine analysts that are presently covering the company, MarketBeat reports. Eight investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $30.00.

A number of analysts recently weighed in on the stock. Piper Sandler reduced their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. HC Wainwright reissued a “buy” rating and set a $30.00 price objective on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Barclays cut their target price on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 12th. Roth Mkm decreased their price target on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research report on Friday, November 8th. Finally, StockNews.com upgraded Aspen Aerogels to a “sell” rating in a report on Wednesday, November 13th.

Check Out Our Latest Analysis on ASPN

Institutional Trading of Aspen Aerogels

Institutional investors have recently made changes to their positions in the stock. FMR LLC lifted its position in Aspen Aerogels by 23.6% in the 3rd quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock worth $112,169,000 after buying an additional 773,647 shares in the last quarter. Driehaus Capital Management LLC raised its holdings in shares of Aspen Aerogels by 130.4% during the second quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock worth $51,439,000 after acquiring an additional 1,220,724 shares in the last quarter. Loomis Sayles & Co. L P boosted its position in Aspen Aerogels by 22.7% during the third quarter. Loomis Sayles & Co. L P now owns 1,619,320 shares of the construction company’s stock valued at $44,839,000 after purchasing an additional 300,076 shares during the last quarter. State Street Corp grew its stake in Aspen Aerogels by 0.6% in the third quarter. State Street Corp now owns 1,410,543 shares of the construction company’s stock valued at $39,058,000 after purchasing an additional 8,344 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in Aspen Aerogels by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock worth $38,385,000 after purchasing an additional 75,024 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Price Performance

Shares of NYSE ASPN opened at $12.02 on Thursday. Aspen Aerogels has a twelve month low of $10.75 and a twelve month high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The firm has a 50-day moving average of $15.05 and a two-hundred day moving average of $21.51. The company has a market capitalization of $986.20 million, a price-to-earnings ratio of 1,203.20 and a beta of 2.11.

About Aspen Aerogels

(Get Free Report

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Articles

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.